Intravitreal versus Subcutaneous Adalimumab in Active Non-Infectious Uveitis: A Randomized Non-Inferiority Trial
IVA was non-inferior to SCA in treating active NIU and resulted in fewer systemic adverse events.
Authors
- Ziyad Mahfoud
- Alaa Bou Ghannam (ORCID: https://orcid.org/0000-0001-6522-9250)
- Rola N. Hamam (ORCID: https://orcid.org/0000-0001-8044-4215)
- Rachid Istambouli (ORCID: https://orcid.org/0000-0002-3900-1938)
- Souha Allam
- Haytham I. Salti (ORCID: https://orcid.org/0000-0003-2424-0212)
- Ahmad M. Mansour (ORCID: https://orcid.org/0000-0001-8430-2214)
- Mahdi M. Hassoun (ORCID: https://orcid.org/0009-0008-6616-5031)
Institutions
- Cornell University (US)
- Abu Dhabi Health Services (AE)
- American University of Beirut Medical Center (LB)
- Weill Cornell Medical College in Qatar (QA)
- Cleveland Eye Clinic (US)
- Weill Cornell Medicine (US)
- Lebanese American University (LB)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-07-13
- DOI
- https://doi.org/10.1080/09273948.2025.2526692
- Citations
- 3
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 5.12